P-tau181 is a biomarker of NFTs and the p-tau181/t-tau ratio has been shown to be a sensitive biomarker for the detection of tauopathies that are similar to CTE (e.g., FTLD) (Meeter et al., 2018). Here, MAPT is linked to tauopathy.